Literature DB >> 3017194

Platelet activating factor: a biologically active phosphoglyceride.

D J Hanahan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017194     DOI: 10.1146/annurev.bi.55.070186.002411

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


× No keyword cloud information.
  121 in total

Review 1.  Age-related changes in wound healing.

Authors:  D R Thomas
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  The regulation and cellular functions of phosphatidylcholine hydrolysis.

Authors:  M M Billah; J C Anthes
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

3.  Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.

Authors:  Kimberly D Dyer; Caroline M Percopo; Zhihui Xie; Zhao Yang; John Dongil Kim; Francis Davoine; Paige Lacy; Kirk M Druey; Redwan Moqbel; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

4.  Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.

Authors:  Elizabeth S Fernandes; Giselle F Passos; Maria M Campos; Glória E P de Souza; Juliana F Fittipaldi; Jorge L Pesquero; Mauro M Teixeira; João B Calixto
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

5.  Lyso platelet activating factor (LysoPAF) and its enantiomer. Total synthesis and carbon-13 NMR spectroscopy.

Authors:  M P Murari; R Murari; S Parthasarathy; C A Guy; V V Kumar; B Malewicz; W J Baumann
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

6.  The significance of endothelin in platelet-activating factor-induced fetal growth restriction.

Authors:  Mark G Neerhof; Saira Khan; Sylvia Synowiec; Xiao-Wu Qu; Larry G Thaete
Journal:  Reprod Sci       Date:  2012-04-25       Impact factor: 3.060

7.  A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.

Authors:  D Weissman; G Poli; A Bousseau; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Platelet-Activating Factor Quantification Using Reversed Phase Liquid Chromatography and Selected Reaction Monitoring in Negative Ion Mode.

Authors:  Daniel P Pike; Celine L Hartman; Gregory J Weissler; Elisa N D Palladino; Carolyn J Albert; David A Ford
Journal:  Lipids       Date:  2016-10-18       Impact factor: 1.880

9.  Enhanced embryo development of rabbit oocytes fertilized in vitro with platelet activating factor (PAF)-treated spermatozoa.

Authors:  W E Roudebush; A I Fukuda; B S Minhas
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

10.  Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.

Authors:  K Satoh; T Imaizumi; Y Kawamura; H Yoshida; M Hiramoto; S Takamatsu; M Takamatsu
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.